CDX2与Barrett食管的相关性研究
被引量:2
摘要
本文采用免疫组化的方法分别检测了CDX2在RE、BE、BE旁2cm内鳞状上皮组织及食管腺癌中的表达,旨在探讨CDX2与BE发生与演变的相关性。
出处
《中外医疗》
2010年第13期40-40,42,共2页
China & Foreign Medical Treatment
参考文献5
-
1Shaheen NJ,Crosby MA,Bozymski EM,et al.Is there publication bias in the reporting of cancer risk in Barrett's esophagus[J].Gastroenterology,2000,119:333-338.
-
2刘新光.胆汁反流与Barrett食管[J].实用医院临床杂志,2004,1(3):9-10. 被引量:3
-
3CHEN X,YANG C S.Esophageal adenocarcinoma:a review and perspectives on the mechanism of carcinogenesis and chemoprevention[J].Carcinogenesis,2001,22(8):1119-1129.
-
4Marchetti M,Caliot E.Pringault E.J Cell Sci,2003,116(Pt8):1429- 1436.
-
5L M G Moons,D A Bax,E J Kuipers.et al.The homeodomain protein CDX2 is an early marker of Barrett's oesophagus[J].J Clin Pathol,.
二级参考文献10
-
1[1]Zaninotto G,Portale G,Parenti A,et al. Role of acid and bile reflux in development of specialised intestinal metaplasia in distal oesophagus [ J ]. Dig Liver Dis, 2002,34: 251 ~ 7.
-
2[2]Smythe A, Bird NC,Troy GP,et al. Effect cisapride on oesophageal motility and duodenogastro-oesophageal ferlux in patients with Barrett's oesophagus [ J ]. Eur J Gastroenterol Hepatol, 1997, 9 ( 2 ):1149 ~ 53.
-
3[3]Stipa F,Stein HJ,Feussner H,et al.Assessment of non-acid esophageal reflux:comparison between long-term reflux aspiration test and fiberoptic bilirubin montoring[J ]. Dis Esophagus, 1997,10( 1 ) :24 ~ 8.
-
4[4]Kauer WK,Peters JH,De Meester TR,et al.Composition and concentratioo of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease [J ] .Surgery, 1997,122(5) :874 ~ 81.
-
5[5]Bechi P, Ciauchi F, Mazzanti R, et al. Reflux and pH: 'alkaline' components are not neutralized by gastric pH variations [ J ] . Dis Esophagus ,2000, 13( 1 ) :51 ~ 5.
-
6[6]Nehra D, Howell P, Williams CP, et al.Toxic bile acid in gastroosophageal reflux disease:influence of gastric acidity[ J ]. Gut, 1999,44(5) :598 ~ 602.
-
7[7]Gopal DV.Another look at Barrett's esophagus Current thinking on screening and surveillance strategies [ J ] . Postgrad Med, 2001, 110(3) :57 ~ 68.
-
8[8]Shirvani VN, Ouatu-lascar R, Kaur BS, et al. Cyclooxygenase 2 expre -ssion in Barrett's esophagus and adenocarcinoma: Exvivo induction by bile and acid exposure [ J ]. Gastroenterology, 2000, 118 (3): 487 ~96.
-
9[9]Kaur BS,Triadafilopoulos G.Acid-and bile-induced PGE2 release and hyperproliferation in Barrett's esophagus are Cox-2 and PKC-epsilon dependent [J ] .Am J Physiol Gastrointest Liver Physiol ,2002,283(2):327~34.
-
10[10]Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. Inflammatory gradient in Barrett's oesophagus implications for disease complications[J ]. Gut, 2002,51: 316 ~ 22.
同被引文献20
-
1Cameron M Smith,David I Watson,Michael Z Michael,Damian J Hussey.MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma[J].World Journal of Gastroenterology,2010,16(5):531-537. 被引量:23
-
2房殿春,许国铭,赵晶京.Barrett食管诊治共识(草案)[J].胃肠病学,2006,11(1):46-47. 被引量:12
-
3侯培珍,张娟,赵永峰,侯先文,王睿琦.中西药结合对胃癌多药耐药的逆转和诱导凋亡作用[J].第四军医大学学报,2008,29(13):1181-1183. 被引量:11
-
4杨叶,侯培珍,张娟.川芎嗪联合氟尿嘧啶对胃癌细胞SGC-7901/ADR的杀伤作用[J].肿瘤防治研究,2008,35(9):624-626. 被引量:13
-
5汪兴伟,房殿春,郜恒骏,徐梅,徐江涛,杨仕明,孙永刚.Barrett食管基因差异表达谱初步探讨[J].胃肠病学,2008,13(10):603-606. 被引量:4
-
6卢晓敏.Barrett食管组织中P53蛋白的表达及其临床意义[J].山西医药杂志(下半月),2008,37(11):972-973. 被引量:1
-
7郝旺胜,侯先文,张娟,侯培珍,王睿琦.斑贞1号联合氟尿嘧啶对胃癌细胞SGC-7901/ADR的细胞毒作用[J].临床荟萃,2008,23(24):1762-1764. 被引量:8
-
8季语祝,王芳,黄慧.骨形成蛋白与肿瘤转移[J].肿瘤学杂志,2009,15(4):350-351. 被引量:2
-
9张永宏,吴兴龙,周力.COX-2在Barrett食管中的表达及意义[J].贵阳医学院学报,2009,34(2):170-172. 被引量:2
-
10李震萍,李晓燕.CDX2和MUC2检测提高反流性食管炎及Barrett食管诊断率[J].医学信息(内.外科版),2009,22(9):818-821. 被引量:3
二级引证文献4
-
1何名梅.连萸清降汤联合西药治疗反流性食管炎疗效及对P16、P53、PCNA表达的影响[J].现代中西医结合杂志,2017,26(2):144-146. 被引量:12
-
2郑婷婷,叶蔚,叶斌,刘彬彬.越鞠丸加味对反流性食管炎大鼠食管黏膜PCNA、p53、CyclinD1表达的影响[J].中国中医药科技,2018,25(2):184-187. 被引量:7
-
3张园,彭伯坚,张拥军,骆凤娇.脂多糖诱导食管鳞状上皮细胞表达BMP4的研究[J].中国医学创新,2018,15(15):24-27.
-
4詹东梅,刘延庆.中药逆转胃癌多药耐药的研究进展[J].癌症进展,2020,18(13):1307-1311. 被引量:8
-
1贺明.CDX2在Barrett食管中的表达[J].中国误诊学杂志,2007,7(8):1742-1743.
-
2吴锟,王晓通,谢玉波,肖强.Cdx2-siRNA对胃癌MGC-803细胞黏附能力的影响[J].中华实验外科杂志,2011,28(12):2151-2151. 被引量:2
-
3林金祥,王文睿,庄聪文,张哲明,曾志勇.Barrett食管与食管腺癌诊治体会[J].东南国防医药,2004,6(2):100-101.
-
4章振林,何进卫,黄琪仁,秦跃娟,胡云秋,李淼,张浩,刘玉娟,胡伟伟.维生素D受体基因起始密码子和CDX2多态性与钙剂补充对绝经后妇女骨密度作用的关系[J].中华医学遗传学杂志,2006,23(4):397-401. 被引量:7
-
5薛寒冰,戈之铮.Barrett食管诊断与治疗研究进展[J].国外医学(消化系疾病分册),2005,25(3):163-165. 被引量:2
-
6顾洁梅,何进卫,肖文金,胡伟伟,张浩,胡云秋,李淼,傅文贞,刘玉娟,汪纯,柯耀华,岳华,章振林.维生素D受体基因和雌激素受体基因多态性与老年人低骨量的关系[J].中华骨质疏松和骨矿盐疾病杂志,2010,3(3):171-177. 被引量:7
-
7陈伟,梁力建.胆囊功能的再认识[J].中国实用外科杂志,2015,35(9):926-928. 被引量:17
-
8熊理守,陈旻湖.Barrett食管的诊断[J].中国消化内镜,2008,2(12):16-19.
-
9Pultrum B.B.,Bijleveld C.M.,De Langen Z.J.,Plukker J.Th.M.,刘凯.先天性食管闭锁成形术后22年发生的食管腺癌[J].世界核心医学期刊文摘(儿科学分册),2006,2(6):34-35.
-
10PeterJ.Kahrilas 王殊.反流性疾病的外科治疗[J].美国医学会杂志(中文版),2002,21(2):104-105.